Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451497
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-14
Brief Title:
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor:
Organization:
Zumutor Biologics Inc